| Product Code: ETC7731410 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Angioedema Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Angioedema Market - Industry Life Cycle |
3.4 Japan Angioedema Market - Porter's Five Forces |
3.5 Japan Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Japan Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 Japan Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Japan Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 Japan Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 Japan Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Japan Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of angioedema in Japan |
4.2.2 Technological advancements in diagnosis and treatment of angioedema |
4.2.3 Rising awareness about angioedema among healthcare professionals and patients |
4.3 Market Restraints |
4.3.1 High cost associated with treatment and management of angioedema |
4.3.2 Limited availability of specialized healthcare facilities for angioedema patients in Japan |
5 Japan Angioedema Market Trends |
6 Japan Angioedema Market, By Types |
6.1 Japan Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Japan Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 Japan Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 Japan Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 Japan Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 Japan Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 Japan Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 Japan Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 Japan Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Japan Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 Japan Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 Japan Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 Japan Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 Japan Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 Japan Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 Japan Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 Japan Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 Japan Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 Japan Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 Japan Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 Japan Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 Japan Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 Japan Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 Japan Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 Japan Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 Japan Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 Japan Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 Japan Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 Japan Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 Japan Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 Japan Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Japan Angioedema Market Import-Export Trade Statistics |
7.1 Japan Angioedema Market Export to Major Countries |
7.2 Japan Angioedema Market Imports from Major Countries |
8 Japan Angioedema Market Key Performance Indicators |
8.1 Number of new diagnosed cases of angioedema in Japan |
8.2 Adoption rate of advanced diagnostic techniques for angioedema |
8.3 Patient satisfaction with angioedema treatment options |
8.4 Average time taken for diagnosis and initiation of treatment for angioedema |
8.5 Rate of adherence to prescribed treatment regimens for angioedema |
9 Japan Angioedema Market - Opportunity Assessment |
9.1 Japan Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Japan Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 Japan Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 Japan Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 Japan Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 Japan Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 Japan Angioedema Market - Competitive Landscape |
10.1 Japan Angioedema Market Revenue Share, By Companies, 2024 |
10.2 Japan Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here